In a separate experiment the ability of this vaccination protocol to protect against the development of blood-stage malaria was evaluated and compared to that in recipients of PBS, Vaxfectin plus a DNA construct encoding only hMIP3α without the fCSP component, and Vaxfectin and a DNA construct encoding CSP without hMIP3α. Here, DNAJC5 is linked to malaria.